Form 4: Bath & Body Works Executive Exercises Stock Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Thomas E. Mazurek, Chief Supply Chain Officer of Bath & Body Works, exercised stock options and sold a portion of the acquired shares on March 27, 2024.

Summary

  • On March 27, 2024, Thomas E. Mazurek, Chief Supply Chain Officer of Bath & Body Works, exercised stock options to acquire 2,285 shares of common stock at a price of $43.7529 per share.
  • Simultaneously, Mazurek sold 4,285 shares of common stock at a weighted average price of $48.8949, with individual sales ranging from $48.84 to $48.985.
  • Following these transactions, Mazurek directly owns 45,992 shares of Bath & Body Works common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. These transactions are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Executive compensation packages often include stock options to align management's interests with those of shareholders.
  • The exercise and sale of shares by executives are typical occurrences, and the timing and volume can vary based on individual financial planning and company performance.
  • Comparable companies in the retail sector, such as Lululemon, American Eagle, and Abercrombie & Fitch, also have executives who regularly report similar transactions.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • Shareholders may view insider transactions as a signal, but this particular transaction appears routine.

Key Dates

DateDescription
03/31/2017Original date exercisable for stock options
03/31/2024Expiration date for stock options
03/27/2024Date of stock option exercise and share sale
03/28/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.